ERBB3 and head and neck squamous cell carcinoma: Upregulation of ErbB3 signaling has been identified as a mechanism of acquired cetuximab resistance in HPV-negative HNSCC cell lines and xenograft models, including the novel mechanism of autocrine NRG1 secretion [12,13,14].